Check back soon for news and updates.
2020
-
Endpoints: The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn’t going to stop them
Media Coverage - -
Encoded Therapeutics Announces $135 Million Series D Financing to Support First Clinical Trials in SCN1A+ Dravet Syndrome and Advance Preclinical Pipeline of Gene Therapies for Debilitating Neurological Disorders
Press Release - -
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Press Release -
2019
-
Encoded Therapeutics Strengthens Senior Leadership Team with Key Appointments in Regulatory and Human Resources Functions
Press Release - -
Encoded Therapeutics Expands Leadership Team with Key Appointments, Adding Expertise in Manufacturing and Corporate Development
Press Release - -
Xconomy: Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
Media Coverage - -
FierceBiotech: Encoded Therapeutics bags $104M to propel ‘precision gene therapy’ for Dravet syndrome
Media Coverage - -
Endpoints News: After raising $158M, this upstart’s founders have star backers and plans to break new ground in gene therapy
Media Coverage - -
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Press Release -